Diagnos Inc.
DGNOF
$0.16
$0.002.17%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.30K | 10.90K | 11.00K | 14.00K | 12.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.30K | 10.90K | 11.00K | 14.00K | 12.80K |
| Cost of Revenue | -811.90K | 299.20K | 272.70K | 283.20K | -477.20K |
| Gross Profit | 823.20K | -288.30K | -261.70K | -269.20K | 490.10K |
| SG&A Expenses | 567.80K | 479.80K | 474.40K | 480.10K | 701.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 832.20K | 779.10K | 747.10K | 763.30K | 917.00K |
| Operating Income | -820.90K | -768.10K | -736.10K | -749.30K | -904.20K |
| Income Before Tax | -851.70K | -832.90K | -796.00K | -804.60K | -931.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -851.70K | -832.90K | -796.00K | -804.60K | -931.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -851.70K | -832.90K | -796.00K | -804.60K | -931.80K |
| EBIT | -820.90K | -768.10K | -736.10K | -749.30K | -904.20K |
| EBITDA | -818.80K | -765.70K | -711.40K | -725.00K | -901.10K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 109.20M | 117.40M | 102.26M | 101.86M | 98.98M |
| Average Diluted Shares Outstanding | 109.20M | 117.40M | 102.26M | 101.86M | 98.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |